SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM • FR0013154002

180.95 EUR
-1.8 (-0.98%)
Last: Feb 26, 2026, 01:07 PM
Fundamental Rating

4

DIM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. DIM has an average financial health and profitability rating. DIM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DIM had positive earnings in the past year.
  • DIM had a positive operating cash flow in the past year.
  • Of the past 5 years DIM 4 years were profitable.
  • DIM had a positive operating cash flow in 4 of the past 5 years.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • DIM has a worse Return On Assets (3.36%) than 61.11% of its industry peers.
  • The Return On Equity of DIM (6.55%) is comparable to the rest of the industry.
  • DIM's Return On Invested Capital of 5.94% is in line compared to the rest of the industry. DIM outperforms 50.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DIM is in line with the industry average of 9.63%.
  • The last Return On Invested Capital (5.94%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.36%
ROE 6.55%
ROIC 5.94%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • DIM has a better Profit Margin (8.98%) than 61.11% of its industry peers.
  • In the last couple of years the Profit Margin of DIM has declined.
  • With a decent Operating Margin value of 16.63%, DIM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • DIM's Operating Margin has declined in the last couple of years.
  • DIM's Gross Margin of 45.64% is fine compared to the rest of the industry. DIM outperforms 61.11% of its industry peers.
  • DIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.63%
PM (TTM) 8.98%
GM 45.64%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DIM is creating some value.
  • There is no outstanding debt for DIM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • DIM has an Altman-Z score of 4.08. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
  • DIM has a Altman-Z score of 4.08. This is amongst the best in the industry. DIM outperforms 83.33% of its industry peers.
  • DIM has a debt to FCF ratio of 6.84. This is a slightly negative value and a sign of low solvency as DIM would need 6.84 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.84, DIM is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
  • A Debt/Equity ratio of 0.50 indicates that DIM is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.50, DIM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Altman-Z 4.08
ROIC/WACC0.65
WACC9.17%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • DIM has a Current Ratio of 1.05. This is a normal value and indicates that DIM is financially healthy and should not expect problems in meeting its short term obligations.
  • DIM's Current ratio of 1.05 is on the low side compared to the rest of the industry. DIM is outperformed by 61.11% of its industry peers.
  • DIM has a Quick Ratio of 1.05. This is a bad value and indicates that DIM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DIM's Quick ratio of 0.50 is on the low side compared to the rest of the industry. DIM is outperformed by 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.5
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

  • DIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.71%, which is quite impressive.
  • DIM shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.13% yearly.
EPS 1Y (TTM)25.71%
EPS 3Y-20.14%
EPS 5Y1.13%
EPS Q2Q%8.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.78%

3.2 Future

  • DIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.33% yearly.
  • The Revenue is expected to grow by 10.83% on average over the next years. This is quite good.
EPS Next Y21.28%
EPS Next 2Y21.44%
EPS Next 3Y22.34%
EPS Next 5Y18.33%
Revenue Next Year8.64%
Revenue Next 2Y9.88%
Revenue Next 3Y11.44%
Revenue Next 5Y10.83%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 41.12, which means the current valuation is very expensive for DIM.
  • 72.22% of the companies in the same industry are cheaper than DIM, based on the Price/Earnings ratio.
  • DIM is valuated expensively when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 33.91 indicates a quite expensive valuation of DIM.
  • Based on the Price/Forward Earnings ratio, DIM is valued a bit more expensive than 66.67% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DIM to the average of the S&P500 Index (28.03), we can say DIM is valued slightly more expensively.
Industry RankSector Rank
PE 41.12
Fwd PE 33.91
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • DIM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DIM is more expensive than 72.22% of the companies in the same industry.
  • DIM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 47.02
EV/EBITDA 24.8
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DIM does not grow enough to justify the current Price/Earnings ratio.
  • DIM's earnings are expected to grow with 22.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.93
PEG (5Y)36.45
EPS Next 2Y21.44%
EPS Next 3Y22.34%

4

5. Dividend

5.1 Amount

  • DIM has a yearly dividend return of 0.41%, which is pretty low.
  • DIM's Dividend Yield is a higher than the industry average which is at 0.44.
  • Compared to an average S&P500 Dividend Yield of 1.80, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.41%

5.2 History

  • The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • DIM pays out 25.37% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of DIM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.37%
EPS Next 2Y21.44%
EPS Next 3Y22.34%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

SARTORIUS STEDIM BIOTECH

EPA:DIM (2/26/2026, 1:07:53 PM)

180.95

-1.8 (-0.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-03
Earnings (Next)N/A
Inst Owners11.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.61B
Revenue(TTM)N/A
Net Income(TTM)264.50M
Analysts78.95
Price Target246.59 (36.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.41%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP25.37%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.99%
Min EPS beat(2)-2.24%
Max EPS beat(2)10.22%
EPS beat(4)3
Avg EPS beat(4)9.45%
Min EPS beat(4)-2.24%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-1.58%
EPS beat(12)3
Avg EPS beat(12)-11.08%
EPS beat(16)4
Avg EPS beat(16)-13.1%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-3.94%
Max Revenue beat(2)0.3%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.94%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)7
Avg Revenue beat(16)-0.72%
PT rev (1m)-0.29%
PT rev (3m)3.24%
EPS NQ rev (1m)-0.7%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0.65%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-0.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.38%
Valuation
Industry RankSector Rank
PE 41.12
Fwd PE 33.91
P/S 5.98
P/FCF 47.02
P/OCF 24.1
P/B 4.36
P/tB N/A
EV/EBITDA 24.8
EPS(TTM)4.4
EY2.43%
EPS(NY)5.34
Fwd EY2.95%
FCF(TTM)3.85
FCFY2.13%
OCF(TTM)7.51
OCFY4.15%
SpS30.27
BVpS41.47
TBVpS-4.02
PEG (NY)1.93
PEG (5Y)36.45
Graham Number64.07
Profitability
Industry RankSector Rank
ROA 3.36%
ROE 6.55%
ROCE 7.46%
ROIC 5.94%
ROICexc 6.26%
ROICexgc 21.64%
OM 16.63%
PM (TTM) 8.98%
GM 45.64%
FCFM 12.71%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexgc growth 3Y-36.77%
ROICexgc growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Debt/EBITDA 2.5
Cap/Depr 112.98%
Cap/Sales 12.09%
Interest Coverage 3.09
Cash Conversion 90.75%
Profit Quality 141.63%
Current Ratio 1.05
Quick Ratio 0.5
Altman-Z 4.08
F-Score8
WACC9.17%
ROIC/WACC0.65
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.71%
EPS 3Y-20.14%
EPS 5Y1.13%
EPS Q2Q%8.74%
EPS Next Y21.28%
EPS Next 2Y21.44%
EPS Next 3Y22.34%
EPS Next 5Y18.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.78%
Revenue Next Year8.64%
Revenue Next 2Y9.88%
Revenue Next 3Y11.44%
Revenue Next 5Y10.83%
EBIT growth 1Y25.48%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year93.64%
EBIT Next 3Y36.06%
EBIT Next 5Y26.76%
FCF growth 1Y219.35%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y15.98%
OCF growth 3Y5.11%
OCF growth 5Y21.32%

SARTORIUS STEDIM BIOTECH / DIM.PA FAQ

What is the fundamental rating for DIM stock?

ChartMill assigns a fundamental rating of 4 / 10 to DIM.PA.


What is the valuation status of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (DIM.PA). This can be considered as Overvalued.


What is the profitability of DIM stock?

SARTORIUS STEDIM BIOTECH (DIM.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

The Price/Earnings (PE) ratio for SARTORIUS STEDIM BIOTECH (DIM.PA) is 41.12 and the Price/Book (PB) ratio is 4.36.


What is the earnings growth outlook for SARTORIUS STEDIM BIOTECH?

The Earnings per Share (EPS) of SARTORIUS STEDIM BIOTECH (DIM.PA) is expected to grow by 21.28% in the next year.